Wang et al. reported an elevated MAP3K1 expression in glioma, which was negatively associated with a poor prognosis, and could promote the sensibility of GBM cell to TMZ and radiotherapy by combining with TRIB2 [9]. The gene discussed is MAP3K1; the disease is glioblastoma.